Healthcare workers, academic and medical researchers, colleagues, community and other New York heroes — here are their stories and latest news.
We are open for elective surgeries and procedures. For everyone’s safety, we have designated treatment areas for non-COVID-19 patients, and we have gone beyond industry standards to implement the most rigorous COVID-SAFE Care protocols currently available. Now more than ever, it’s important to not put your healthcare needs on hold.
Montefiore’s Chief Psychologist, Dr. Simon Rego discusses the psychological impact of the COVID-19 lockdown and having a lack of “social rhythm reinforcers” like school, social events or the gym.
Out-of-hospital heart attacks in NYC nearly tripled during the height of the COVID-19 pandemic—peaking on April 6, 2020 with 305 cases, an almost 10x increase from the same day in 2019—according to a study published in JAMA Cardiology by Dr. David Prezant of Montefiore, Albert Einstein College of Medicine and FDNY.
In Dr. Ozuah’s NYT op-ed, he writes: “I see rare hope that these twin disasters disproportionately hurting minorities — one a brand-new virus and the other a virus as old as the country itself — could finally prove the true strength of our shared humanity.”
Montefiore-Einstein's research reveals nearly all newborns born to COVID-19-positive mothers tested negative for the disease immediately after birth, according to the largest body of data in the U.S. about pregnant women & COVID.
Dr. H. Michael Ushay of Children’s Hospital at Montefiore tells NY1 that Montefiore-Einstein has seen 37 Multisystem Inflammatory Syndrome in Children (MIS-C) patients, most of whom have been discharged, and the most reassuring aspect of the illness is how well children respond to treatment.
In the midst of a pandemic that has paralyzed the world, a CBS News team spent 7 days on the frontline at Montefiore-Einstein capturing the bravery and hope of our healthcare heroes who have been courageously fighting COVID-19.
Dr. Nadine Choueiter of Children’s Hospital at Montefiore speaks to NBC New York about rare cases of Pediatric Multisystem Inflammatory Syndrome (PMIS) related to COVID-19 and the importance of identifying symptoms so it can be treated.
Following promising results from NIH’s remdesivir trial, Montefiore-Einstein has begun testing a new drug combination as the next stage of the Adaptive COVID-19 Treatment Trial (ACTT2) — remdesivir and baricitinib. This may be the key to treating the most severe COVID-19 cases.
The Department of Pediatrics at Montefiore-Einstein conducted the largest single-center U.S. study researching how children are affected by COVID-19. While most children infected with COVID-19 have mild symptoms, a small number experience a severe response.
Dr. Philip O. Ozuah, CEO of Montefiore Medicine, spoke to MSNBC’s Morning Joe about testing, clinical trials, and the heroic fight, praising the courageous frontline workers at Montefiore.
New York Times' Nicholas Kristof tells the compelling story of Montefiore's ER Doctor Andres Maldonado who was diagnosed with COVID-19 and brought to the ICU after treating patients on the frontlines of the pandemic.
Researchers at Montefiore-Einstein conducted the largest study so far to assess outcomes for patients with cancer who have also been infected with #COVID19. The study, published in the online edition of Cancer Discovery, provides guidance on how to help protect this vulnerable patient population.
Montefiore-Einstein, one of the locations participating in the remdesivir clinical trial, has enrolled 91 patients in the study to test its effectiveness in treating #COVID19. Dr. Barry Zingman, Clinical Director, Infectious Diseases and Professor of Medicine, discusses promising early findings of remdesivir trial with NBC.
Doctors from Montefiore Health System applied for an emergency grant to purchase essential items such as diapers, wipes and formula for patient care packages. News 12 The Bronx highlights our #Monteheroes' efforts to get critical items directly to mothers and their babies in need amid the #COVID19 crisis.
Why do men infected by COVID-19 generally show more severe symptoms and why are they are more likely than women to die from the virus? Researchers at Montefiore-Einstein showed for the first time that men clear the virus from their bodies slower than women. The explanation: a potential male-only “reservoir” for coronavirus.
Dr. Liise-anne Pirofski, Chief of Infectious Disease, Department of Medicine at Montefiore Health System, speaks to CNN about a new clinical trial to treat individuals infected with COVID-19.